Kynurenine pathway and links to cell senescence

No Pathway Network information available for Kynurenine pathway and links to cell senescence

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Kynurenine pathway and links to cell senescence SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Congenital nad deficiency disorderEnrichmentHAAO, KYNU5.23
2Rhabdomyosarcoma 2EnrichmentFOXO1, TP534.60
3Diffuse large b-cell lymphomaEnrichmentFOXO1, TP533.37
4Bladder cancerEnrichmentCDKN1A, TP533.00
5HydroxykynureninuriaEnrichmentKYNU2.99
6Vertebral, cardiac, renal, and limb defects syndrome 2EnrichmentKYNU2.99
7HypertryptophanemiaEnrichmentTDO22.99
8Retinitis pigmentosa 85EnrichmentAHR2.79
9Immunodeficiency 69EnrichmentIFNG2.79
10Bone marrow failure syndrome 5EnrichmentTP532.79
11Papilloma of choroid plexusEnrichmentTP532.79
12Basal cell carcinoma 7EnrichmentTP532.79
13Foveal hypoplasia 3EnrichmentAHR2.79
14Leukoencephalopathy, motor delay, spasticity, and dysarthria syndromeEnrichmentEIF2AK12.79
15Anaplastic thyroid carcinomaEnrichmentTP532.79
16Macular degeneration, age-related, 10EnrichmentTLR42.79
17Ductal carcinoma in situEnrichmentTP532.79
18Thyroid gland undifferentiated carcinomaEnrichmentTP532.79
19Small-cell carcinoma of the ovary of hypercalcemic typeEnrichmentTP532.79
20Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtypeEnrichmentTP532.79
21Choroid plexus cancerEnrichmentTP532.79
22Pleomorphic xanthoastrocytomaEnrichmentTP532.79
23Vertebral, cardiac, renal, and limb defects syndrome 1EnrichmentHAAO2.69
24Catel-manzke syndromeEnrichmentKYNU2.69
25Adrenocortical carcinoma, hereditaryEnrichmentTP532.49
26Pulmonary venoocclusive disease 1, autosomal dominantEnrichmentEIF2AK42.49
27Cervical cancerEnrichmentTP532.49
28Pulmonary venoocclusive disease 2, autosomal recessiveEnrichmentEIF2AK42.49
29Lymphoma, hodgkin, classicEnrichmentTP532.49
30Cardiomyopathy, dilated, 1ffEnrichmentKLF52.49
31Pulmonary venoocclusive disease 1EnrichmentEIF2AK42.49
32Pulmonary venoocclusive disease 2EnrichmentEIF2AK42.49
33Leukodystrophy, hypomyelinating, 17EnrichmentEIF2AK12.49
34Immunodeficiency 127EnrichmentTNF2.49
35Congenital fibrosarcomaEnrichmentTP532.49
36Li-fraumeni syndrome 1EnrichmentTP532.49
37SarcomaEnrichmentTP532.49
38Cervix carcinomaEnrichmentTP532.49
39Hodgkin's lymphomaEnrichmentTP532.49
40Pulmonary venoocclusive diseaseEnrichmentEIF2AK42.49
41Pleomorphic rhabdomyosarcomaEnrichmentTP532.49
42Tuberous sclerosis 1EnrichmentIFNG2.31
43Osteogenic sarcomaEnrichmentTP532.31
44Psoriatic arthritisEnrichmentTNF2.31
45Hepatitis c virusEnrichmentIFNG2.31
46Nasopharyngeal carcinomaEnrichmentTP532.31
47Tuberous sclerosis 2EnrichmentIFNG2.31
48Atypical teratoid rhabdoid tumorEnrichmentTP532.31
49Anaplastic astrocytomaEnrichmentTP532.31
50Squamous cell carcinomaEnrichmentTP532.31
51AdenocarcinomaEnrichmentTP532.31
52Migraine without auraEnrichmentTNF2.31
53Bone osteosarcomaEnrichmentTP532.31
54Small cell cancer of the lungEnrichmentTP532.19
55Thyroid cancer, nonmedullary, 1EnrichmentTP532.19
56Lung sarcomatoid carcinomaEnrichmentTP532.19
57Embryonal rhabdomyosarcomaEnrichmentTP532.19
58Cerebral malariaEnrichmentTNF2.19
59LymphomaEnrichmentTP532.09
60Vascular dementiaEnrichmentTNF2.09
61Acute megakaryocytic leukemiaEnrichmentTP532.09
62Idiopathic aplastic anemiaEnrichmentIFNG2.09
63Li-fraumeni syndromeEnrichmentTP532.01
64Adrenocortical carcinomaEnrichmentTP532.01
65Breast adenocarcinomaEnrichmentTP532.01
66Esophageal cancerEnrichmentTP531.95
67Multiple endocrine neoplasia, type iEnrichmentCDKN1A1.95
68Squamous cell carcinoma, head and neckEnrichmentTP531.95
69Essential thrombocythemiaEnrichmentTP531.95
70Gallbladder cancerEnrichmentTP531.95
71B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentTP531.95
72Glioma susceptibility 1EnrichmentTP531.89
73Lymphoma, non-hodgkin, familialEnrichmentTP531.89
74Adult hepatocellular carcinomaEnrichmentTP531.84
75Primary hyperaldosteronismEnrichmentTP531.84
76Leukemia, chronic lymphocyticEnrichmentTP531.79
77Aplastic anemiaEnrichmentIFNG1.79
78Familial colorectal cancerEnrichmentTP531.79
79AsthmaEnrichmentTNF1.75
80Myelodysplastic syndromeEnrichmentTP531.75
81Heritable pulmonary arterial hypertensionEnrichmentEIF2AK41.75
82Lip and oral cavity carcinomaEnrichmentTP531.71
83Pulmonary hypertension, primary, 1EnrichmentEIF2AK41.68
84Alzheimer's diseaseEnrichmentTNF1.68
85Lung cancer susceptibility 3EnrichmentTP531.65
86RhabdomyosarcomaEnrichmentTP531.59
87GliosarcomaEnrichmentTP531.59
88Giant cell glioblastomaEnrichmentTP531.56
89Human immunodeficiency virus type 1EnrichmentIFNG1.54
90Behcet syndromeEnrichmentTLR41.52
91HepatoblastomaEnrichmentTP531.47
92Hepatocellular carcinomaEnrichmentTP531.45
93Multisystem inflammatory syndrome in childrenEnrichmentIFNB11.45
94Diamond-blackfan anemia 1EnrichmentTP531.44
95MalariaEnrichmentTNF1.44
96Pancreatic cancerEnrichmentTP531.40
97Prostate cancerEnrichmentTP531.34
98Diamond-blackfan anemiaEnrichmentTP531.25
99Systemic lupus erythematosusEnrichmentTNF1.21
100Leukemia, acute myeloidEnrichmentTP531.20
101Gastric cancerEnrichmentTP531.17
102Hereditary breast carcinomaEnrichmentTP531.16
103Hereditary breast ovarian cancer syndromeEnrichmentTP531.07
104Myeloma, multipleEnrichmentTP531.06
105Breast cancerEnrichmentTP530.94
106Colorectal cancerEnrichmentTP530.88
107Ovarian cancerEnrichmentTP530.82
108Inherited cancer-predisposing syndromeEnrichmentTP530.71
109Retinitis pigmentosaEnrichmentAHR0.53

Loading...
Loading...
Loading...